Related by context. Frequent words. (Click for all words.) 64 Receives Orphan Drug Designation 61 Initiates Phase II 61 Completes Enrollment 60 Enrolls First 60 commercialize telaprevir 60 candidates bavituximab 60 R sorafenib tablets 59 hepatitis B HBV 59 Onalta 59 Presents Positive 59 topical anti infective 59 inflammatory autoimmune diseases 58 R bortezomib 58 Meets Primary Endpoint 57 investigational mTOR inhibitor 57 ThermoDox R 57 Taiho Pharmaceutical Co. 57 Kuvan R 57 Initiates Phase 57 Daclizumab 57 PEG PAL PEGylated recombinant 57 TELINTRA 57 Pivotal Phase III 57 phenylalanine ammonia lyase 57 refractory chronic lymphocytic 57 histone deacetylase HDAC inhibitor 56 Application MAA 56 TRANSDUR Sufentanil 56 Pivotal Study 56 Amrubicin 56 Injectable Suspension 56 Rebif ® 56 fibrosis IPF 56 developing Zerenex TM 56 cutaneous T 56 Genasense ® 56 Advancing Drugs 56 phenylketonuria PKU developed 56 Nexavar ® 56 Announces Initiation 56 Subcutaneous Use 55 addressing idiopathic pulmonary 55 gets USFDA nod 55 oncology indications 55 immunological disorders 55 Clevudine 55 Drug Candidate 55 diarrhea CDAD 55 Irinotecan 55 MKC# 55 Takeda Kyowa Hakko Kirin 55 undergoing coronary angioplasty 55 Soliris TM eculizumab 55 hepatitis C HCV 55 Phase III Clinical Trial 55 Shigamabs ® 55 Cetrorelix 55 lung pancreatic 55 Frova R 55 Signs License Agreement 55 candidate AP# 55 Commences Phase 55 Panzem R 54 GVAX R 54 Inhalation Aerosol 54 subcutaneous formulation 54 include LibiGel ® 54 intravenous formulations 54 Dapagliflozin 54 HepeX B 54 Oral Suspension Oral Suspension 54 Single Dose 54 cervical breast 54 candidate Zenvia 54 Ciclesonide 54 Inc Therapeutic Competitors 54 Chronic Idiopathic Constipation 54 Mitsubishi Tanabe Pharma 54 Topotecan 54 investigational compounds 54 perifosine novel potentially 54 granted Orphan Drug 54 Receives FDA Clearance 54 dipropionate 54 post herpetic neuralgia PHN 54 Phase III Trial 54 commercializing therapeutic 54 Copegus R 54 CEQ# 54 Shigamabs R 53 FACTIVE R gemifloxacin 53 Announces FDA Clearance 53 paroxysmal nocturnal hemoglobinuria PNH 53 pramlintide acetate injection 53 chemotherapy induced neutropenia 53 Orphan Drug designation 53 Announces Positive 53 Therapeutic Competitors 53 GVAX cancer 53 JAK inhibitor 53 Alzhemed TM